Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article . 2023
License: CC BY
Data sources: Datacite
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article . 2023
License: CC BY
Data sources: Datacite
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article . 2023
License: CC BY
Data sources: ZENODO
versions View all 2 versions
addClaim

NOVEL NUTRACEUTICAL COMPOUNDS IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEUROLOGICAL DISORDERS

Authors: Muhammad Fahaam Javidakhtar Shaikh;

NOVEL NUTRACEUTICAL COMPOUNDS IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEUROLOGICAL DISORDERS

Abstract

Alzheimer's disease (AD), which affects up to 50 million people globally today, is one of the biggest mysteries in medical science and public health systems. This complex brain condition is characterized by apathy, mood and neuropsychiatric abnormalities, as well as gradual cognitive impairment. Ageing is the primary risk factor for AD; it is a normal biologicalprocedure connected to a continuous dynamic that involves a progressive loss of people's physical capabilities, but with a reliable, lived-in perspective on life. According to studies, AD differs from healthy ageing in that it causes changes in the processes that safeguard neurons as well as their powerful functioning capabilities. Given the components of nutrition, regular exercise, and avoiding certain substances, a significant route has been created towards preventing AD in this environment. Avoiding harmful chemicals and narcotics, maintaining an active social life, engaging in meditation, and managing stress are all necessary for healthy ageing. Here, we examine how these elements are involved and how to reduce environmental risk factors for a higher standard of living. both proactive and creative, the use of trustworthy biomarkers in screening programs for early disease identification is becoming increasingly important for disease management.Additionally, the failure of conventional pharmaceutical therapies and the search for new medications have sparked the development of nutraceutical compounds in the context of "multi-target" therapy, as well as mindfulness techniques that are effective in the management of AD and ageing.All of these preventive measures combined with cutting-edge pharmaceutical techniques should form the basis of an integrated strategy for the eventual control of the illness. According to studies, AD is different from healthy ageing in that it causes alterations in the processes that safeguard neurons while maintaining their great functioning capabilities. Given that daily exercise, healthy eating, and avoiding harmful chemicals are all critical components of AD prevention, an important road has been opened in this regard.drugs, a bustling social life, meditation, and stress management are all necessary for good ageing. Here, we examine how these elements are involved and how to reduce risk factors from the environment for a higher standard of living. The control of the illness is increasingly dependent on prevention as well as cutting-edge screening programmes for early diagnosis of the disease utilizing accurate biomarkers. Additionally, the ineffectiveness of conventional pharmaceutical therapies and the quest for novel medicationshas sparked the development of nutraceutical substances in the framework of a "multitarget" therapy, as well as methods of mindfulness that have been shown useful for the management of ageing and AD. All of these protective factors coupled with an integrated strategy,The future management of the condition should be made possible by innovative pharmaceutical techniques.

Keywords

Alzheimer's Disease, Biomarkers, Non-Pharmacological Treatment, Nutraceutical Compounds, Prevention, A Neurological Disorder.

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
    OpenAIRE UsageCounts
    Usage byUsageCounts
    visibility views 5
    download downloads 6
  • 5
    views
    6
    downloads
    Powered byOpenAIRE UsageCounts
Powered by OpenAIRE graph
Found an issue? Give us feedback
visibility
download
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
views
OpenAIRE UsageCountsViews provided by UsageCounts
downloads
OpenAIRE UsageCountsDownloads provided by UsageCounts
0
Average
Average
Average
5
6
Green
Related to Research communities